Gilead Sciences upgraded by HSBC Securities with a new price target
Stocks in this Quantisnow insightHealth Care
Keep researching GILD
- What is Analyst upgrade?A sell-side analyst's move to a more favorable rating on a stock, such as from Hold to Buy, usually published with a new price target and thesis.
- Analyst upgrades and downgradesAn analyst upgrade or downgrade is a change in a sell-side analyst's stock rating. Learn what Buy, Hold and Sell mean, how price targets work and which changes matter.
- GILD insider tradesEvery buy and sale reported by Gilead Sciences Inc. officers, directors and large holders.
- GILD earnings historyPast Gilead Sciences Inc. earnings releases, newest first.
- GILD financial statementsRevenue, profit, cash flow and balance sheet from Gilead Sciences Inc.'s SEC filings.
Quantisnow market dataNASDAQ
GILD
Gilead Sciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 1992
Get push alerts for GILD
Full GILD profile on Quantisnow Follow GILD and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time